DEUTSCHE BANK AG\ - ONCOLYTICS BIOTECH INC ownership

ONCOLYTICS BIOTECH INC's ticker is ONCYF and the CUSIP is 682310107. A total of 38 filers reported holding ONCOLYTICS BIOTECH INC in Q4 2013. The put-call ratio across all filers is 1.52 and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of ONCOLYTICS BIOTECH INC
ValueSharesWeighting
Q2 2015$21,000
+2000.0%
43,200
+2060.0%
0.00%
Q1 2015$1,0002,000
+300.0%
0.00%
Q4 2014$0
-100.0%
500
-98.0%
0.00%
Q2 2014$31,000
+181.8%
24,500
+282.8%
0.00%
Q1 2014$11,000
+57.1%
6,400
+39.1%
0.00%
Q4 2013$7,0004,600
+4500.0%
0.00%
Q3 2013$01000.00%
Other shareholders
ONCOLYTICS BIOTECH INC shareholders Q4 2013
NameSharesValueWeighting ↓
SOPHROSYNE CAPITAL LLC 222,900$345,0000.30%
ACUITY INVESTMENT MANAGEMENT INC 69,300$108,0000.04%
VSR Financial Services, Inc. 357,770$554,0000.04%
1832 Asset Management L.P. 2,704,900$4,227,0000.02%
Paradigm Financial Advisors, LLC 9,558$15,0000.02%
AGF INVESTMENTS INC. 860,749$1,345,0000.01%
BANK OF MONTREAL /CAN/ 1,833,669$2,842,0000.00%
BANK OF NOVA SCOTIA 500,000$781,0000.00%
RUSSELL FRANK CO/ 1,005,900$1,553,0000.00%
First Eagle Investment Management, LLC 427,200$662,0000.00%
View complete list of ONCOLYTICS BIOTECH INC shareholders